[Aplastic anemia and pure red cell aplasia].
Aplastic anemia (AA) is a disorder characterized by the presence of pancytopenia and a hypocellular bone marrow. Acquired pure red cell aplasia (PRCA), a part of a unique form of AA, is a rare condition of profound anemia characterized by the absence of reticulocytes and the virtual absence of erythroid precursors in the bone marrow. AA can be effectively treated by either stem cell transplantation or immunosuppressive therapy. However, PRCA has so far been treated by several different regimens which are largely empirically selected since so little control data are available. This issue focuses on the current progress in the treatment of acquired AA and PRCA.
Sawada
Kenichi
K
Department of Internal Medicine III, Akita University Graduate School of Medicine.
Hirokawa
Makoto
M
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000741:Anemia, Aplastic / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D010951:Plasma Exchange; D012010:Red-Cell Aplasia, Pure / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D012720:Severity of Illness Index
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016179:Granulocyte Colony-Stimulating Factor; D016572:Cyclosporine; D003520:Cyclophosphamide